共 48 条
- [41] Quality of Life in Patients With Malignant Ascites and Ascites Symptoms After Treatment With Catumaxomab: Results From a Multicenter Phase II/III Study Comparing Paracentesis Plus Catumaxomab With Paracentesis AloneEUROPEAN JOURNAL OF CANCER, 2011, 47 : S223 - S223Gonschior, A.Gilet, H.Heisss, M. M.Hennig, M.Moehler, M.Schmalfeldt, B.Schulze, E.Wimberger, P.Parsons, S. L.
- [42] Effect of enhanced external counterpulsation on symptoms, quality of life, 6-minute walking distance, and left ventricular systolic and diastolic function after 35 days of treatment and at 1-year follow-up in 47 patients with chronic refractory anginaJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A222 - A222Kurna, AnilAronow, Wilbert S.Vadnerkar, AniketSidhu, PuneetMittal, SanjayKasliwal, Ravi R.Trehan, Naresh
- [43] Effects of tadalafil treatment after bilateral nerve-sparing radical prostatectomy: quality of life, psychosocial outcomes, and treatment satisfaction results from a randomized, placebo-controlled phase IV studyBMC UROLOGY, 2015, 15Patel, Hitendra R.Ilo, DapoShah, NimishCuzin, BeatriceChadwick, DavidAndrianne, RobertHenneges, CarstenBarry, JaneHell-Momeni, KatjaBranicka, JuliaBuettner, Hartwig
- [44] Effects of tadalafil treatment after bilateral nerve-sparing radical prostatectomy: quality of life, psychosocial outcomes, and treatment satisfaction results from a randomized, placebo-controlled phase IV studyBMC Urology, 15Hitendra R PatelDapo IloNimish ShahBéatrice CuzinDavid ChadwickRobert AndrianneCarsten HennegesJane BarryKatja Hell-MomeniJulia BranickaHartwig Büttner
- [45] Late Toxicity and Quality of Life from GETUG-AFU 22 Study: A Multicenter Randomized Phase II Trial Comparing Radiotherapy +/-6 Months of Degarelix as a Salvage Treatment for Patients with Detectable PSA after Radical ProstatectomyINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S134 - S134Latorzeff, I.Guerif, S.Fraisse, J.Meyer, E.Supiot, S.Lagneau, E.Deniaud-Alexandre, E.Ronchin, P.Benyoucef, A.Cartier, L.Hamidou, H.Hasbini, A.Crehange, G.Pommier, P.Magne, N.Pelissier, S.Gross, E.Fourneret, P.Salomon, L.Sargos, P.
- [46] Twice-daily balsalazide tablets improve patient quality of life after 2 and 8 weeks of treatment: Results of a phase 3, randomized, double-blind, placebo-controlled, multicenter studyGASTROENTEROLOGY, 2008, 134 (04) : A494 - A494Rubin, David T.Rosen, Alan A.Sedghi, ShahriarShepard, Roland D.Mareya, Shadreck M.Huang, ShirleyShaw, Audrey L.Forbes, William P.
- [47] Effect of Enhanced External Counterpulsation on Clinical Symptoms, Quality of Life, 6-Minute Walking Distance, and Echocardiographic Measurements of Left Ventricular Systolic and Diastolic Function After 35 Days of Treatment and at 1-Year Follow Up in 47 Patients With Chronic Refractory Angina PectorisAMERICAN JOURNAL OF THERAPEUTICS, 2009, 16 (02) : 116 - 118Kumar, AnilAronow, Wilbert S.Vadnerkar, AniketSidhu, PuneetMittal, SanjayKasliwal, Ravi R.Trehan, Naresh
- [48] Bimekizumab Shows Sustained and Meaningful Long-Term Improvements in Health-Related Quality of Life in Ankylosing Spondylitis: Interim Results After 3 Years of Treatment in an Ongoing Phase 2b StudyARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1918 - 1921Deodhar, AtulDougados, MaximeGaffney, KarlSengupta, RajMagrey, Marinade Peyrecave, NatashaOortgiesen, MargaVaux, ThomasFleurinck, CarmenTaieb, Vanessade la Loge, ChristineBaraliakos, Xenofon